Project Updates

Alnylam, Massachusetts

Credit: Alnylam

Project name: Alnylam’s Manufacturing Facility, US 
Location: Norton, Massachusetts 
Project type: Biopharmaceutical manufacturing facility 
Start of Construction: 2016 
Investment: $200m

Alnylam Pharmaceuticals, has built a new drug manufacturing and cGMP warehouse facility in Norton, Massachusetts, US. The facility produces the company’s RNA interference (RNAi) therapeutics to fulfil global clinical and commercial demand.

Upperton, Nottingham 

Credit: Upperton Pharma Solutions

Project name: Upperton’s Pharmaceutical Development and GMP Manufacturing Facility, UK 
Location: Nottingham, UK 
Project type: Development and GMP manufacturing facility 
Area: 50,000ft2 
Estimated Investment: £15m ($18.7m)

Upperton Pharma Solutions, a CDMO is building a new development and GMP headquarters in Nottingham, to support early formulation development and early-to-late-stage clinical trials product supplies.

Lonza, Visp

Credit: Lonza

Project name: Lonza’s Bioconjugation Facility Expansion, Visp 
Location: Visp, Switzerland 
Project type: Bioconjugation facility expansion 
Announced: December 2020 
Owner: Lonza

Lonza completed the expansion of its bioconjugation facility in Visp, Switzerland in February 2023. The expansion improved the facility’s bioconjugation capabilities and helped in meeting the increased demand for bioconjugates.